Peanut Allergy
Research Study
Researchers at Lurie Children's Hospital of Chicago and Alliance are partnering with people allergic to peanuts to investigate a potential treatment. Join our compensated study today!
Fast Facts
18-25 Years Old
peanut allergy
no previous peanut oral immunotherapy in past year
Compensation up to $665 Provided
conducted in Chicago, IL
Study Background
Researchers from the Alliance Allergy Study are conducting a research study to evaluate the safety and tolerability of a peanut oral immunotherapy.
Food allergies affect around 5 to 10% of individuals throughout the world. They happen when the immune system does not accept certain proteins in some foods. Peanut allergy is one of the most common food allergies in children. It usually starts
when individuals are very young, and then, for many, it stays even into adult life. Currently, the main way to manage peanut allergy is by being very careful to stay away from peanuts or by using emergency medicine.
This study is testing a study drug for individuals with peanut allergy. Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public.
Further research today and join our compensated study!
Study Background
Researchers from the Alliance Allergy Study are conducting a research study to evaluate the safety and tolerability of a peanut oral immunotherapy.
Food allergies affect around 5 to 10% of individuals throughout the world. They happen when the immune system does not accept certain proteins in some foods. Peanut allergy is one of the most common food allergies in children. It usually starts
when individuals are very young, and then, for many, it stays even into adult life. Currently, the main way to manage peanut allergy is by being very careful to stay away from peanuts or by using emergency medicine.
This study is testing a study drug for individuals with peanut allergy. Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public.
Further research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria:
Key Criteria:
- Between 18-25 years old
- Documented history of a peanut allergy
- No previous peanut oral immunotherapy within the last year
- No history of eosinophilic esophagitis (EoE)
- No history of uncontrolled asthma
- No history of mouth sores, lesions, or inflammation
- No history of cardiovascular disease
Once enrolled, this study involves:
- Participating in five in-person visits
- Undergoing food challenges, labs, and skin prick testing
- Completing four scheduled telephone follow-ups
